Behavioral Health & Substance Use Treatment

MDRXLaw represents behavioral health and substance use treatment providers — including outpatient clinics, residential treatment programs, psychiatric practices, psychology groups, and OASAS/OMH-licensed facilities — across New York, New Jersey, and Pennsylvania, with clients nationwide. The firm advises on licensure and certification, Medicaid and commercial payer compliance, mental health and substance use parity issues, 42 CFR Part 2 confidentiality requirements, telehealth prescribing, fraud and abuse risk, and the emerging compliance obligations created by AI-driven clinical tools. With deep healthcare regulatory experience and a proven record defending providers in audits and enforcement matters, MDRXLaw helps behavioral health and substance use treatment organizations grow and operate with confidence in a heavily regulated, fast-changing environment.

OUR EXPERIENCE

Behavioral health and substance use treatment providers operate at the intersection of some of the most complex regulatory regimes in healthcare — state licensure requirements, federal confidentiality protections, insurance parity mandates, and rapidly evolving rules around telehealth and AI-assisted care. For outpatient clinics, residential and inpatient programs, psychiatric and psychology practices, and medication-assisted treatment providers, a misstep in any one of these areas can jeopardize licensure, reimbursement, and reputation.

MDRXLaw's healthcare attorneys understand the day-to-day realities of running a behavioral health or substance use treatment organization and provide practical, business-focused legal guidance tailored to the sector.

How We Help

  • Licensure & Certification

    Applications, renewals, and change of ownership filings with state agencies such as OASAS and OMH, and other state behavioral health regulators.

  • Medicaid & Insurance Compliance

    Enrollment, billing compliance, and defense against Medicaid and commercial payer audits and overpayment allegations.

  • Mental Health & Substance Use Parity

    Guidance on compliance with federal and state parity laws governing coverage and reimbursement for behavioral health services.

  • 42 CFR Part 2 & HIPAA Compliance

    Advising on the heightened confidentiality requirements unique to substance use disorder treatment records, alongside general HIPAA obligations.

  • Telehealth & Prescribing

    Counsel on telehealth service delivery and controlled substance prescribing rules, including DEA telehealth flexibilities for behavioral health and MAT providers.

  • AI Governance & Compliance

    Guidance on the compliance obligations created by AI-driven clinical, documentation, and administrative tools in psychology and psychiatric practices under existing legal frameworks.

  • Regulatory Investigations & Enforcement Defense

    Representing providers in state and federal investigations, including OMIG, OIG, and Medicaid Fraud Control Unit inquiries.

  • Fraud & Abuse Compliance

    Anti-Kickback Statute, Stark Law, and False Claims Act risk assessments, including issues specific to patient brokering and referral arrangements in substance use treatment.

  • Credentialing & Staffing

    Guidance on clinician licensure, supervision requirements, and staffing compliance across disciplines.

  • Business & Corporate Transactions

    Mergers, acquisitions, joint ventures, and corporate structuring for behavioral health and treatment organizations.

  • Litigation & Dispute Resolution

    Representing providers in contract disputes, licensing appeals, and litigation, including through MDRXResolve, our dedicated mediation platform for healthcare providers.

From licensure through litigation, MDRXLaw delivers the industry-specific knowledge and responsive advocacy that behavioral health and substance use treatment providers need to navigate a demanding regulatory landscape.

LATEST INSIGHTS AND PUBLICATIONS